{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:30Z","timestamp":1793325690585,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1053\/j.ajkd.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:27:40Z","timestamp":1697196460000},"page":"549-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy"],"prefix":"10.1053","volume":"83","author":[{"given":"Ilya","family":"Glezerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Michelle","family":"Brauer Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ajkd.2023.08.014_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40259-013-0070-1","article-title":"Pegylated liposomal doxorubicin: a guide to its use in various malignancies","volume":"27","author":"Lyseng-Williamson","year":"2013","journal-title":"BioDrugs"},{"key":"10.1053\/j.ajkd.2023.08.014_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120358","article-title":"Uptake and release profiles of PEGylated liposomal doxorubicin nanoparticles: a comprehensive picture based on separate determination of encapsulated and total drug concentrations in tissues of tumor-bearing mice","volume":"208","author":"Wang","year":"2020","journal-title":"Talanta"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.014_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-017-3420-8","article-title":"Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value","volume":"80","author":"Skubitz","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.014_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2004.03.024","article-title":"Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies","volume":"94","author":"Uyar","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.08.014_bib5","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res"},{"issue":"5","key":"10.1053\/j.ajkd.2023.08.014_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2015.02.340","article-title":"Thrombotic microangiopathy, cancer, and cancer drugs","volume":"66","author":"Izzedine","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2023.08.014_bib7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1634\/theoncologist.2011-0422","article-title":"Is renal thrombotic angiopathy an emerging problem in the treatment of ovarian cancer recurrences?","volume":"17","author":"Kwa","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.014_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ki.2013.411","article-title":"The authors reply","volume":"85","author":"Jhaveri","year":"2014","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2023.08.014_bib9","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1177\/1078155218798157","article-title":"Renal toxicity with liposomal doxorubicin in metastatic breast cancer","volume":"25","author":"Yemm","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"5","key":"10.1053\/j.ajkd.2023.08.014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100461","article-title":"Pegylated liposomal doxorubicin and kidney-limited thrombotic microangiopathy in a kidney transplant recipient: a case report","volume":"4","author":"Rodriguez-Ramirez","year":"2022","journal-title":"Kidney Med"},{"issue":"2","key":"10.1053\/j.ajkd.2023.08.014_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00280-020-04203-z","article-title":"Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review","volume":"87","author":"Savani","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.08.014_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/j.ajkd.2012.08.048","article-title":"Collapsing glomerulopathy following anthracycline therapy","volume":"61","author":"Mohamed","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2023.08.014_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000188623","article-title":"Nephrotic syndrome developed in a patient with acute promyelocytic leukemia treated with daunomycin","volume":"70","author":"Morino","year":"1995","journal-title":"Nephron"},{"issue":"1","key":"10.1053\/j.ajkd.2023.08.014_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","article-title":"Glomerular diseases seen with cancer and chemotherapy: a narrative review","volume":"84","author":"Jhaveri","year":"2013","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623008533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623008533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:51:41Z","timestamp":1759463501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623008533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0272638623008533"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.014","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}